Tag Archives: spec

September, 2015

9 September
Biosimilars’ Success in the US: Will Physicians Rule the Road?

By Kathleen P. Wolff, MBA Specialty Pharma Journal As the high cost of new biologic medicines sends U.S. healthcare costs soaring, payers are anxiously anticipating the introduction of biosimilar medicines – biological products, approved by FDA because they are highly similar to an already FDA-approved biological product. However, there is one …
Share

1 April
Registration Open for Biosimilars 20/20: The Next Five Years

TAMPA, FL, April 1, 2015 – The Specialty Pharma Education Center (SPEC) and Specialty Pharma Journal (SPJ) today announced that registration is now open for Biosimilars 20/20, scheduled for June 3-4, 2015 at The Hub in Philadelphia, PA. Biosimilars 20/20 promises to provide an in-depth look into the future of the …
Share

9 March
The Specialty Pharma Education Center (SPEC) Offers Accredited Education Free of Charge

TAMPA, FL, March 9, 2015 — The Specialty Pharma Education Center (SPEC), a global leader in specialty pharmacy education, announced that it no longer requires users to be members of the National Association of Specialty Pharmacy (NASP) to access the education center. The move paves the way for greater participation …
Share

24 February
Specialty Pharma Journal (SPJ) and Specialty Pharma Education Center (SPEC) Partner for Business-Based Educational Programs in Specialty Pharmacy

Tampa, FL, February 24, 2015 — Specialty Pharma Journal (SPJ) announced today that it has partnered with the Specialty Pharma Education Center (SPEC) to bring business-based educational programs to the specialty pharmacy industry. SPJ and SPEC are developing programs dedicated to education in biosimilars, 340B contracting, co-pay and coupon adjudication guidelines in …
Share